Recent advances in Immuno-oncology, changes in lifestyle brought on by urbanization, which predisposes populations to cancer, and the increased acceptability of targeted therapy are all contributing to the growth. The global immuno-oncology clinical trials market was valued at USD 5.3 billion in 2020, with a compound annual growth rate (CAGR) of 13.6 percent predicted from…